Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis.

Kim CJ, Nazli A, Rojas OL, Chege D, Alidina Z, Huibner S, Mujib S, Benko E, Kovacs C, Shin LY, Grin A, Kandel G, Loutfy M, Ostrowski M, Gommerman JL, Kaushic C, Kaul R.

Mucosal Immunol. 2012 Nov;5(6):670-80. doi: 10.1038/mi.2012.72. Epub 2012 Aug 1.

PMID:
22854709
2.

Enteric mucosa integrity in the presence of a preserved innate interleukin 22 compartment in HIV type 1-treated individuals.

Fernandes SM, Pires AR, Ferreira C, Foxall RB, Rino J, Santos C, Correia L, Poças J, Veiga-Fernandes H, Sousa AE.

J Infect Dis. 2014 Aug 15;210(4):630-40. doi: 10.1093/infdis/jiu126. Epub 2014 Mar 5.

PMID:
24604817
3.

Th17 cells, HIV and the gut mucosal barrier.

Dandekar S, George MD, Bäumler AJ.

Curr Opin HIV AIDS. 2010 Mar;5(2):173-8. doi: 10.1097/COH.0b013e328335eda3. Review.

PMID:
20543596
4.

IL-17-producing innate lymphoid cells are restricted to mucosal tissues and are depleted in SIV-infected macaques.

Xu H, Wang X, Liu DX, Moroney-Rasmussen T, Lackner AA, Veazey RS.

Mucosal Immunol. 2012 Nov;5(6):658-69. doi: 10.1038/mi.2012.39. Epub 2012 Jun 6.

5.

Human immunodeficiency virus and the gastrointestinal immune system: does highly active antiretroviral therapy restore gut immunity?

Costiniuk CT, Angel JB.

Mucosal Immunol. 2012 Nov;5(6):596-604. doi: 10.1038/mi.2012.82. Epub 2012 Aug 29. Review.

PMID:
22929559
6.

Preferential and persistent depletion of CCR5+ T-helper lymphocytes with nonlymphoid homing potential despite early treatment of primary HIV infection.

Krzysiek R, Rudent A, Bouchet-Delbos L, Foussat A, Boutillon C, Portier A, Ingrand D, Sereni D, Galanaud P, Grangeot-Keros L, Emilie D; ANRS O86 PRIMOFERON A Study Group.

Blood. 2001 Nov 15;98(10):3169-71.

7.

Sigmoid Th17 populations, the HIV latent reservoir, and microbial translocation in men on long-term antiretroviral therapy.

Chege D, Sheth PM, Kain T, Kim CJ, Kovacs C, Loutfy M, Halpenny R, Kandel G, Chun TW, Ostrowski M, Kaul R; Toronto Mucosal Immunology Group.

AIDS. 2011 Mar 27;25(6):741-9. doi: 10.1097/QAD.0b013e328344cefb.

PMID:
21378536
8.

HIV infection and the intestinal mucosal barrier.

Epple HJ, Zeitz M.

Ann N Y Acad Sci. 2012 Jul;1258:19-24. doi: 10.1111/j.1749-6632.2012.06512.x. Review.

PMID:
22731711
9.

Disturbance of the gut-associated lymphoid tissue is associated with disease progression in chronic HIV infection.

Hofer U, Speck RF.

Semin Immunopathol. 2009 Jul;31(2):257-66. doi: 10.1007/s00281-009-0158-3. Epub 2009 May 30.

PMID:
19484240
10.

Loss of IL-17-producing CD8 T cells during late chronic stage of pathogenic simian immunodeficiency virus infection.

Nigam P, Kwa S, Velu V, Amara RR.

J Immunol. 2011 Jan 15;186(2):745-53. doi: 10.4049/jimmunol.1002807. Epub 2010 Dec 10.

11.

Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.

Plana M, García F, Gallart T, Tortajada C, Soriano A, Palou E, Maleno MJ, Barceló JJ, Vidal C, Cruceta A, Miró JM, Gatell JM.

AIDS. 2000 Sep 8;14(13):1921-33.

PMID:
10997396
12.

Depletion of natural killer cells in the colonic lamina propria of viraemic HIV-1-infected individuals.

Mela CM, Steel A, Lindsay J, Gazzard BG, Gotch FM, Goodier MR.

AIDS. 2007 Oct 18;21(16):2177-82.

PMID:
18090044
13.

Dominant role for TL1A/DR3 pathway in IL-12 plus IL-18-induced IFN-gamma production by peripheral blood and mucosal CCR9+ T lymphocytes.

Papadakis KA, Zhu D, Prehn JL, Landers C, Avanesyan A, Lafkas G, Targan SR.

J Immunol. 2005 Apr 15;174(8):4985-90.

14.

Differentiation and recruitment of IL-22-producing helper T cells stimulated by pleural mesothelial cells in tuberculous pleurisy.

Ye ZJ, Zhou Q, Yuan ML, Du RH, Yang WB, Xiong XZ, Huang B, Shi HZ.

Am J Respir Crit Care Med. 2012 Mar 15;185(6):660-9. doi: 10.1164/rccm.201107-1198OC. Epub 2011 Dec 28.

PMID:
22199006
15.

Loss of Th22 cells is associated with increased immune activation and IDO-1 activity in HIV-1 infection.

Page EE, Greathead L, Metcalf R, Clark SA, Hart M, Fuchs D, Pantelidis P, Gotch F, Pozniak A, Nelson M, Boasso A, Gazzard B, Kelleher P.

J Acquir Immune Defic Syndr. 2014 Nov 1;67(3):227-35. doi: 10.1097/QAI.0000000000000294.

PMID:
25314246
16.

Mucosal Th17 cell function is altered during HIV infection and is an independent predictor of systemic immune activation.

Kim CJ, McKinnon LR, Kovacs C, Kandel G, Huibner S, Chege D, Shahabi K, Benko E, Loutfy M, Ostrowski M, Kaul R.

J Immunol. 2013 Sep 1;191(5):2164-73. doi: 10.4049/jimmunol.1300829. Epub 2013 Jul 26.

17.

Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection.

Tincati C, Biasin M, Bandera A, Violin M, Marchetti G, Piacentini L, Vago GL, Balotta C, Moroni M, Franzetti F, Clerici M, Gori A.

Antivir Ther. 2009;14(3):321-30.

PMID:
19474466
18.

A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3alpha, by gut epithelial cells.

Caruso R, Fina D, Peluso I, Stolfi C, Fantini MC, Gioia V, Caprioli F, Del Vecchio Blanco G, Paoluzi OA, Macdonald TT, Pallone F, Monteleone G.

Gastroenterology. 2007 Jan;132(1):166-75. Epub 2006 Oct 1.

PMID:
17241869
19.

Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro.

Clerici M, Lucey DR, Berzofsky JA, Pinto LA, Wynn TA, Blatt SP, Dolan MJ, Hendrix CW, Wolf SF, Shearer GM.

Science. 1993 Dec 10;262(5140):1721-4.

PMID:
7903123
20.

Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation.

Schuetz A, Deleage C, Sereti I, Rerknimitr R, Phanuphak N, Phuang-Ngern Y, Estes JD, Sandler NG, Sukhumvittaya S, Marovich M, Jongrakthaitae S, Akapirat S, Fletscher JL, Kroon E, Dewar R, Trichavaroj R, Chomchey N, Douek DC, O Connell RJ, Ngauy V, Robb ML, Phanuphak P, Michael NL, Excler JL, Kim JH, de Souza MS, Ananworanich J; RV254/SEARCH 010 and RV304/SEARCH 013 Study Groups.

PLoS Pathog. 2014 Dec 11;10(12):e1004543. doi: 10.1371/journal.ppat.1004543. eCollection 2014 Dec.

Supplemental Content

Support Center